Kristen K. Buck
2022
In 2022, Kristen K. Buck earned a total compensation of $1.1M as Executive Vice President of Research Development and Chief Medical Officer at Caladrius Biosciences.
Compensation breakdown
| Bonus | $376,388 |
|---|---|
| Option Awards | $20,122 |
| Salary | $553,781 |
| Stock Awards | $165,560 |
| Other | $8,250 |
| Total | $1,124,102 |
Buck received $553.8K in salary, accounting for 49% of the total pay in 2022.
Buck also received $376.4K in bonus, $20.1K in option awards, $165.6K in stock awards and $8.3K in other compensation.
Rankings
In 2022, Kristen K. Buck's compensation ranked 2,810th out of 5,760 executives tracked by ExecPay. In other words, Buck earned more than 51.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,810 out of 5,760 | 51st |
Division Manufacturing | 1,568 out of 3,136 | 50th |
Major group Chemicals And Allied Products | 727 out of 1,422 | 49th |
Industry group Drugs | 679 out of 1,323 | 49th |
Industry Pharmaceutical Preparations | 492 out of 969 | 49th |
Source: SEC filing on April 29, 2024.
Buck's colleagues
We found two more compensation records of executives who worked with Kristen K. Buck at Caladrius Biosciences in 2022.